Development and evaluation of in situ novel intragastric controlled-release formulation of hydrochlorothiazide

M. Kuentz and D. Rothlisberger, Determination of the optimal amount of water in liquidfill masses for hard gelatin capsules by means of texture analysis and experimental design, Int. J. Pharm. 236 (2002) 145-152; DOI: 10.1016/S0378-5173(02)00022-4.10.1016/S0378-5173(02)00022-4Search in Google Scholar

P. Kozlov and G. Burdygina, The structure and properties of solid gelatin and the principles of their modification, Polymer 24 (1983) 651-666; DOI: 10.1016/0032-3861(83)90001-0.10.1016/0032-3861(83)90001-0Search in Google Scholar

E. T. Cole, D. Cade and H. Benameur, Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Adv. Drug Del. Rev. 60 (2008) 747-756; DOI: 10.1016/j.addr.2007.09.009.10.1016/j.addr.2007.09.009Search in Google Scholar

G. Reich, Effect of sorbitol specification on structure and properties of soft gelatin capsules, Pharm. Ind. 58 (1996) 941-946.Search in Google Scholar

S. Nagata, Advantages to HPMC capsules: A new generation's hard capsule, Drug Del. Technol. 2 (2002) 6-9.Search in Google Scholar

S. K. Dordunoo, J. L. Ford and M. H. Rubinstein. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or gelucire 44/14 for liquid filling of hard gelatin capsules, Drug Dev. Ind. Pharm. 17 (1991) 1685-1713; DOI: 10.3109/03639049109057315.10.3109/03639049109057315Search in Google Scholar

W. J. Bowtle and N. J. Barker, A new approach to vancomycin formulation using filling technology for semisolid matrix capsules, Pharm. Tech. 12 (1988) 86-97.Search in Google Scholar

Unated States Pharmacopoeia 28, National Formulary 23, USP Convention, Rockville (MD), Asian Edition, 2005.Search in Google Scholar

K. A. Shah, J. W. Warren, G. Onwuelezi, J. S. Benmaman and C. M. Monk, In vitro release of hydrochlorothiazide from capsule formulations, Drug Dev. Ind. Pharm. 7 (1981) 683-691; DOI: 10.3109/03639048109055692.10.3109/03639048109055692Search in Google Scholar

P. R. Petrovick, M. Jacob, D. Gaudy, V. Bassani and S. Guterres, Influence of adjuvants on the in vitro dissolution of hydrochlorothiazide from hard gelatin capsules, Int. J. Pharm. 76 (1991) 49-53; DOI: 10.1016/0378-5173(91)90342-L.10.1016/0378-5173(91)90342-LSearch in Google Scholar

S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo and D. Attwood, Comparison of in situ gelling formulations for the oral delivery of cimetidine, Int. J. Pharm. 220 (2001) 161-168; DOI: 10.1016/S0378-5173(01)00669-X.10.1016/S0378-5173(01)00669-XSearch in Google Scholar

V. Shah, Y. Tsong, P. Sathe and J. Liu, In vitro dissolution profile comparison-statistics and analysis of the similarity factor f2, Pharm. Res. 15 (1998) 889-896; DOI: 10.1023/A:1011976615750.10.1023/A:1011976615750Search in Google Scholar

U. S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, FDA CDER, Rockwille (MD) 1997; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237Search in Google Scholar

N. Gatchalian, L. Joseph, C. Westergom and N. Langley, Purity of PEG 400 effects the stability of gelatin capsules, American Accociation of Pharmaceutical Scientists Annual Meeting, November 6-10, 2005, Book of Abstracts, AAPS, Nashville (TN) 2005, R6012.Search in Google Scholar